Levetiracetam Sciecure 100mg/ml concertrate solution for infusion

Strength

規格

500mg/5ml

Product   License

PL 43801/0042   - 0001

Indications

适應症

• on its own   in adults and adolescents from 16 years of age with newly   diagnosed epilepsy, to treat a certain form of epilepsy.

• partial   onset seizures with or without generalisation in adults, adolescents   and children from 4 years of age.

• myoclonic   seizures in adults and adolescents from 12 years of age with juvenile   myoclonic epilepsy.

• primary   generalised tonic-clonic seizures in adults and adolescents from 12 years of age with   idiopathic generalised epilepsy.

•在成人和16歲以下新(xīn)診斷為(wèi)癫痫的青少年中(zhōng)單獨治療某種形式的癫痫。

•成人、青少年和4歲以上兒童的部分(fēn)發作(zuò)性癫痫，伴有(yǒu)或不伴有(yǒu)全身性發作(zuò)

•12歲以下患有(yǒu)青少年肌陣攣性癫痫的成人和青少年的肌陣攣性癫痫發作(zuò)。

•12歲以下患有(yǒu)特發性全身性癫痫的成人和青少年的原發性全身強直陣攣發作(zuò)。

Approved Date

批準日期

15/02/2017

Market   Authorization Holder

持有(yǒu)人

SCIECURE   PHARMA LIMITED

Manufacture

生産(chǎn)商(shāng)

Beijing   Sciecure Pharmaceutical Co., Ltd.

北京世橋生物(wù)制藥有(yǒu)限公(gōng)司